Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.11
+0.11002.75%
Post-market: 4.00-0.1100-2.68%16:29 EST
Volume:214.83K
Turnover:866.04K
Market Cap:39.96M
PE:-0.12
High:4.13
Open:3.90
Low:3.86
Close:4.00
Loading ...

FDA investigates risk of blood cancers from bluebird bio's gene therapy

Reuters
·
28 Nov 2024

BRIEF-FDA Investigating Serious Risk Of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)

Reuters
·
28 Nov 2024

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (Elivaldogene Autotemcel)

THOMSON REUTERS
·
28 Nov 2024

WYNNEFIELD GROUP SENDS DEFINITIVE PROXY MATERIALS TO TECHPRECISION STOCKHOLDERS, INCLUDING A BLUE PROXY CARD AND A LETTER SEEKING TO HOLD MEMBERS OF THE BOARD ACCOUNTABLE FOR YEARS OF POOR OPERATING RESULTS, POOR PERFORMANCE AND A SERIES OF COSTLY STRATEGIC MISSTEPS

PR Newswire
·
25 Nov 2024

Analysts Offer Insights on Healthcare Companies: Benitec Biopharma (BNTC), Bluebird Bio (BLUE) and AC Immune SA (ACIU)

TIPRANKS
·
19 Nov 2024

Analysts Offer Insights on Healthcare Companies: Halozyme (HALO), Bluebird Bio (BLUE) and Spruce Biosciences (SPRB)

TIPRANKS
·
19 Nov 2024

bluebird bio Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
16 Nov 2024

Sector Update: Health Care Stocks Slide Late Afternoon

MT Newswires Live
·
16 Nov 2024

Bluebird Bio Shares Fall After BofA Securities, JPMorgan Downgrades

MT Newswires Live
·
16 Nov 2024

JP Morgan Downgrades Gene Therapy Focused Bluebird Bio, Cites Limited Funding Options

Benzinga
·
16 Nov 2024

bluebird bio Price Target Maintained With a $4.00/Share by RBC Capital

Dow Jones
·
16 Nov 2024

bluebird bio Cut to Neutral From Buy by B of A Securities

Dow Jones
·
16 Nov 2024

BUZZ-Bluebird down after Q3 revenue misses estimates, BofA cuts rating

Reuters
·
16 Nov 2024

Top Calls on Wall Street: Starbucks, United Airlines, Delta Air Lines, Twilio, Morgan Stanley and More

Tiger Newspress
·
15 Nov 2024

bluebird bio Inc : Bofa Global Research Cuts to Neutral From Buy

THOMSON REUTERS
·
15 Nov 2024

Bluebird Bio downgraded to Neutral at BofA on slower expected Lyfgenia ramp

TIPRANKS
·
15 Nov 2024